KELLY MAJORS: Open Payments
NPI 1790233013 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 4 | $408 |
| Kestra Medical Technology Services, Inc. | 1 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: SAPIEN 3 Ultra RESILIA, Assure WCD, LEQVIO, AMVUTTRA, FARXIGA, NEXLETOL, REPATHA, ELIQUIS.
Industry payments across AZ — which companies pay providers there.
